Linda Brower
Medical · Elizabeth City, NCNPI 1083695787
Payments from drug & device makers
Across 557 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mannkind Corporation$2K
- Abbott$2K
- Lilly USA, LLC$972
- Novo Nordisk$813
- Corcept Therapeutics$500
- AbbVie$463
- plus $5K from 44 others
What the payments were for
- Consulting fees$5975%
- Travel & lodging$7587%
- Food & beverage$10,20788%
- Education$370%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,599 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 224 | $247,515 |
| MounjaroTirzepatide | 173 | $182,464 |
| JardianceEmpagliflozin | 139 | $109,832 |
| RybelsusSemaglutide | 69 | $103,682 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $52,360 |
| FarxigaDapagliflozin Propanediol | 50 | $47,340 |
| Tresiba Flextouch U-100Insulin Degludec | 58 | $40,830 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 43 | $38,842 |
| TrulicityDulaglutide | 34 | $35,436 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $27,746 |
| FiaspInsulin Aspart (Niacinamide) | 19 | $25,664 |
| JanuviaSitagliptin Phosphate | 41 | $23,554 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $13,315 |
| SynthroidLevothyroxine Sodium | 125 | $10,390 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 17 | $9,791 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Fiasp, Novolog | $813 | $381,411329 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $972 | $221,572219 claims |
| Boehringer IngelheimJardiance | $383 | $109,832139 claims |
| AstraZenecaFarxiga | $159 | $47,34050 claims |
| MerckJanuvia | $28 | $23,55441 claims |
| AbbVieSynthroid | $463 | $10,390125 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $143 | $1,859229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 878 medical providers in North Carolina.
Other medical in Elizabeth City
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.